Vertex Pharmaceuticals Incorporated

Published : July 02nd, 2015

Business Highlights

( 0 vote, 0/5 ) Print article
  Article Comments Comment this article Rating Follow Company  
0
Send
0
comment

Business Highlights

___

US unemployment falls to 7-year low, but wages are flat

WASHINGTON (AP) -- U.S. unemployment fell to a seven-year low of 5.3 percent and employers hired at a solid pace in June, but other gauges of the job market drew a bleaker picture: A wave of people stopped looking for work, and paychecks failed to budge.

The figures released Thursday capture the persistently uneven nature of the recovery from the Great Recession.

The job market "remains consistent with a two-steps-forward, one-step-back expansion the U.S. economy finds itself in," said Scott Andersen, chief economist at Bank of the West.

The economy gained 223,000 jobs last month, and unemployment edged down from 5.5 percent in May, the Labor Department reported.

___

What crisis? Stronger banks, economies ease fear over Greece

The prospect of a Greek crackup isn't so terrifying anymore.

In 2012, financial markets were rattled by the possibility that Greeks would elect a left-wing government, default on their debts and drop the euro currency. The fears pushed the Standard & Poor's 500 stock index down nearly 10 percent that spring.

Here's how things look now: The left-wing party, Syriza, holds power in Athens. Greece actually did miss a loan payment to the International Monetary Fund late Tuesday. And the nation's future in the eurozone hinges precariously on a referendum Sunday.

Yet investors seem to be taking events in stride. Stocks around the world mostly rose Wednesday.

___

Top US auto safety regulator says Chrysler to face sanctions

WASHINGTON (AP) -- Fiat Chrysler will be punished soon for failing to follow the law in 23 recalls involving more than 11 million vehicles, the nation's top auto safety regulator said Thursday.

But Mark Rosekind, administrator of the National Highway Traffic Safety Administration, wouldn't say what action the agency will take until after a public comment period closes on July 17.

___

Rainbow Facebook photos: Armchair activism or shifting tide?

NEW YORK (AP) -- You may have noticed your Facebook friends getting considerably more colorful.

More than 26 million Facebook profile photos have taken on a rainbow hue in the days since the U.S. Supreme Court ruled on Friday that marriage is a right guaranteed under the Constitution regardless of a person's sexual orientation.

People have been covering their profile photos with the Facebook-supplied overlay that uses the best-known symbol of the lesbian, gay, bisexual and transgender rights movement: the rainbow.

Call it armchair activism. Call it a mark of a shifting tide in public opinion. The rainbows are the latest sign of the important place social media has taken in our lives, when it comes to self-expression, politics and privacy.

___

$18.7B deal clears path for BP to close books on Gulf spill

NEW ORLEANS (AP) -- Trying to close the books on the worst offshore oil spill in U.S. history, BP agreed Thursday to provide billions of dollars in new money to five Gulf Coast states in a deal the company said would bring its full obligations to an estimated $53.8 billion.

Federal and state government officials touted the record-breaking $18.7 billion agreement as a historic milestone in the Gulf Coast's recovery. The Deepwater Horizon disaster killed 11 rig workers and spewed millions of gallons of crude that stained beaches, coated wildlife and polluted marshes.

___

Whole Foods apologizes for pricing problems

NEW YORK (AP) -- Whole Foods Market is apologizing to its shoppers for incorrect pricing, a week after a New York investigation found that the natural food grocer routinely overcharged for prepackaged fruits, vegetables and deli meats.

Robb and Mackey said that the pricing mistakes were unintentional and that the company will increase its training at stores around the county. Going forward, Whole Foods will give items away for free if customers discover they were overcharged. "We apologize to our customers for any discrepancies that may have occurred," the company said in blog post.

___

US factory orders fell 1 percent in May

WASHINGTON (AP) -- Orders to U.S. factories fell in May by the largest amount in three months, while a key category that signals business investment plans dropped for a second month.

Factory orders declined 1 percent in May from April, when orders retreated 0.7 percent, the Commerce Department reported Thursday. Orders in a category that serves as a proxy for business investment were down 0.4 percent.

___

Average US rate on 30-year mortgage rises to 4.08 percent

WASHINGTON (AP) -- Average long-term U.S. mortgage rates rose this week, reaching high levels for the year.

Mortgage giant Freddie Mac said Thursday the average rate on a 30-year fixed-rate mortgage rose to 4.08 percent this week from 4.02 percent a week earlier. The rate on 15-year fixed-rate mortgages increased to 3.24 percent from 3.21 percent.

Mortgage rates have increased in recent weeks, in the midst of the spring home buying season, as the economy has shown signs of improvement.

A year ago, the average 30-year rate was 4.12 percent; the 15-year average was 3.22 percent.

___

Centene makes $6.3B bid for fellow insurer Health Net

Centene has jumped into the mix of managed-care companies scrambling to bulk up as the health care overhaul changes their business with a $6.3-billion bid for fellow insurer Health Net.

The deal announced Thursday gives St. Louis-based Centene a chance to expand in two hot growth areas for health insurers, the state- and federally-funded Medicaid program for the poor and people with disabilities; and the federally-supported Medicare Advantage program, which has seen its overall enrollment triple over the past decade.

___

FDA clears drug for leading form of cystic fibrosis

WASHINGTON (AP) -- Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death. But it will come at a steep price — more than $250,000 for a year's treatment.

The Food and Drug Administration cleared the twice-a-day pill from Vertex Pharmaceuticals Inc. for a variation of cystic fibrosis that affects about 8,500 people in the U.S. who are 12 years and older. The approval notice was posted to the agency's website Thursday.

___

Google's new app blunders by calling black people 'gorillas'

SAN FRANCISCO (AP) -- Google's new image-recognition program misfired badly this week by identifying two black people as gorillas, delivering a mortifying reminder that even the most intelligent machines still have lot to learn about human sensitivity.

The blunder surfaced in a smartphone screen shot posted online Sunday by a New York man on his Twitter account, @jackyalcine. The images showed the recently released Google Photos app had sorted a picture of two black people into a category labeled as "gorillas."

___

3 Supreme Court justices maintain substantial stock holdings

WASHINGTON (AP) -- New personal financial disclosures from the Supreme Court show that Chief Justice John Roberts and two other justices are maintaining significant investments in individual companies' stock.

The details of investments held by Roberts, Justice Samuel Alito and Justice Stephen Breyer are in annual financial reports released Thursday by the federal judiciary.

Roberts holds stock worth $250,000 to $500,000 each in Time Warner Inc. and Microsoft Corp., and smaller investments in other technology and communications companies.

___

Tesla tops 11,000 vehicles delivered in second quarter

PALO ALTO, Calif. (AP) -- Electric car maker Tesla's second-quarter deliveries surged 52 percent to set a company record exceeding 11,000 vehicles.

The Palo Alto, California, company had surpassed 10,000 vehicles for the first time in the first three months of the year and on Thursday said it had broken that record, delivering 11,507 vehicles.

Tesla makes only one car, the Model S sedan, but CEO Elon Musk said last month he expects to begin deliveries of an SUV, the Model X, in three or four months. Tesla began 2015 with 20,000 reservations for the Model X. The company has said it plans to deliver 55,000 Model S sedans and Model X SUVs this year.

___

Cuba launches 1st public Wi-Fi hotspots on Havana avenue

HAVANA (AP) -- Cuban authorities have launched public Wi-Fi hotspots along a main avenue that is the heart of Havana's cultural and social life, the first step in government promises to gradually roll out such connectivity options on an island that the Internet revolution has largely passed by.

Authorities have been installing the boxy white routers on buildings along 23rd Street in the Vedado theater, nightclub and business district in recent weeks, and they apparently went live Wednesday night.

___

By The Associated Press=

The Dow Jones industrial average shed 27.80 points, or 0.2 percent, to 17,730.11. The S&P 500 slipped 0.64 of a point, less than 0.1 percent, to 2,076.78. The Nasdaq composite fell 3.91 points, or less than 0.1 percent, to 5,009.21.

Benchmark U.S. crude fell 3 cents Thursday to close at $56.93 a barrel in New York. Brent crude, a benchmark for international oils used by many U.S. refineries, rose 6 cents to close at $62.07 in London. Wholesale gasoline rose 2.7 cents to close at $2.034 a gallon. Heating oil rose 0.1 cent to close at $1.840 a gallon. Natural gas rose 3.9 cents to close at $2.822 per 1,000 cubic feet.

Read the rest of the article at sg.finance.yahoo.com
Data and Statistics for these countries : Cuba | Greece | All
Gold and Silver Prices for these countries : Cuba | Greece | All

CODE :
Follow and Invest
Add to watch list Add to your portfolio Add or edit a note
Add Alert Add to Watchlists Add to Portfolio Add Note
ProfileMarket
Indicators
VALUE :
Projects & res.
Press
releases
Annual
report
RISK :
Asset profile
Contact Cpy

Vertex Pharma is based in United states of america.

Vertex Pharma is listed in United States of America. Its market capitalisation is US$ 116.6 billions as of today (€ 104.9 billions).

Its stock quote reached its lowest recent point on March 12, 2004 at US$ 10.00, and its highest recent level on September 06, 2024 at US$ 468.00.

Vertex Pharma has 249 070 000 shares outstanding.

Your feedback is appreciated, please leave a comment or rate this article.
Rate : Average note :0 (0 vote) View Top rated
 
Corporate news of
1/27/2016Will Vertex Pharmaceuticals’ Valuation Multiple Improve?
1/26/2016Health Canada Approves PrORKAMBI® (lumacaftor/ivacaftor) - t...
1/26/20165:23 pm Vertex Pharma: Health Canada approves PrORKAMBI
1/26/2016Orkambi: Recent Addition to the Vertex Portfolio
1/26/2016Vertex draws upside bet before earnings
1/25/2016Will Higher Expenses Hurt Vertex's (VRTX) 4Q Earnings?
1/25/2016What Are Wall Street’s Estimates for Vertex Pharmaceuticals?
1/25/2016Vertex Pharmaceuticals: What Are Analysts’ Estimates?
1/20/2016Despite Market and Sector Risks, Why Credit Suisse Now Loves...
1/18/2016Nivalis' N91115 Gets Orphan Drug Status for Cystic Fibrosis
1/15/20164 Biotech Stocks Looking Good this Earnings Season
1/15/2016Vertex Pharmaceuticals (VRTX) Jumps: Stock Moves Up 5.8%
1/5/2016Vertex Announces Upcoming Presentation at the J.P. Morgan He...
12/30/2015Vertex Up 3.2% as Healthcare Sector Continued to Lure Invest...
12/23/2015Vertex Drives IBB’s Large-Caps after Losing for Two Days
12/1/2015Do Hedge Funds Love Intercontinental Exchange Inc (ICE)?
11/27/2015The Zacks Analyst Blog Highlights: BioMarin, Amgen, Vertex, ...
11/23/2015Vertex to Present at the Piper Jaffray Healthcare Conference...
11/23/2015Vertex Appoints Michael J. Parini as Executive Vice Presiden...
11/20/2015Vertex Receives EU Approval for ORKAMBI® (lumacaftor/ivacaft...
11/19/2015Vertex Rises on Two EU Approvals for Drug, Leads XLV’s Large...
11/4/2015Vertex to Present at the Credit Suisse Healthcare Conference...
11/2/2015Health-Care Subpoenas: Should We Start to Worry?
11/2/2015Here’s Why These Four Stocks Are Trending Today
11/2/2015IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Inves...
10/31/2015Vertex Pharma receives subpoena from Department of Justice
10/30/2015Law Offices of Howard G. Smith Commences Investigation on Be...
10/30/2015Vertex, Mylan, CVS subpoenaed by federal agencies
10/30/2015SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On...
10/30/2015Nivalis (NVLS): A Surprise in Store this Earnings Season?
10/29/2015Vertex (VRTX) Posts Narrower Q3 Loss, Ups Kalydeco View
10/29/2015Edited Transcript of VRTX earnings conference call or presen...
10/28/2015Vertex Reports Third Quarter 2015 Financial Results
10/28/2015Vertex reports 3Q loss
10/28/20154:07 pm Vertex Pharma beats by $0.14, beats on revs; raises ...
10/27/2015Will Orkambi Help Vertex (VRTX) Post a Lower Loss in Q3?
10/26/2015Vertex and CRISPR Therapeutics Establish Collaboration to Us...
10/26/20158:03 am Vertex Pharma and CRISPR Therapeutics enter strategi...
10/20/2015Oppenheimer Incrementally More Bullish on Gilead, Remains Ca...
10/12/2015Why Energy Stocks Outperformed the Broad Market on October 6
10/9/2015Vertex to Announce Third Quarter 2015 Financial Results on O...
10/8/2015SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Invest...
10/8/2015Vertex's Kalydeco Gets Priority Review for Expanded Use
10/8/2015Vertex Announces Significant Progress in Its Development Eff...
10/7/2015Supplemental New Drug Application for Use of KALYDECO® (ivac...
10/7/2015Supplemental New Drug Application for Use of KALYDECO® (ivac...
10/7/2015Supplemental New Drug Application for Use of KALYDECO® (ivac...
10/7/2015BioMarin Pharmaceutical Takes a Nosedive Last Week
10/1/2015The Zacks Analyst Blog Highlights: Regeneron, Vertex, Gilead...
9/29/2015Regeneron and Mylan End Up in Green for the Week
9/28/2015Why Argus Thinks Now Is the Time to Buy Vertex
9/25/2015IBB Remained Flat Last Week
9/25/2015Vertex Receives CHMP Positive Opinions for ORKAMBI™ (lumacaf...
9/23/2015XBI’s Biotechnology Stocks Rose Week of September 11
9/22/20155 Biotech Stocks Hit Hard by Hillary Clinton's Tweet
9/22/2015Vertex Outperforms XLV on a Year-to-Date Basis
9/21/2015Biotech stocks fall on Clinton vow to fight 'price gouging'
9/18/2015SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Invest...
9/16/2015XLV and XBI Outperform Benchmark Indexes from August 25–31
9/14/2015Amgen And Biogen Lead Short Interest Surge In Biotechs
9/14/2015Vertex Helps Biotechnology Sector Outperform
9/14/2015How Will Vertex Solve Its Falling Revenue Woes?
9/14/2015Vertex Pharma's Orkambi Gives It Huge Potential, Says Barcla...
9/11/2015Vertex and Biogen Outperformd XLV and SPY
9/8/2015Vertex to Present at the Morgan Stanley Healthcare Conferenc...
8/22/2015How Does Vertex Compare to Its Peers?
8/21/2015Vertex Stock Rises after 2Q15 Results Announcement
8/21/2015Will Orkambi Be a Game Changer for Vertex?
8/19/2015Vertex Awards Two Boston Public High School Students the Ver...
8/11/2015What Drove Vertex’s Revenue in 2Q15?
8/11/2015Vertex Reports 2Q15 Revenues of $166.1 Million
8/11/2015What Led Large-Cap Stocks to Outperform Mid and Small Caps?
8/10/2015Key for Investors: How Are Biotech Stocks Trending?
8/10/2015Biotech Stocks Rise Due to a Stable Market: July 31 Week
8/6/2015The Zacks Analyst Blog Highlights: Amgen, Vertex, Regeneron,...
8/4/20153 Potential Huge Takeover Targets in Biotech
7/31/2015Advanced Estimate: US 2Q Gross Domestic Product Expanded by ...
7/30/2015Vertex Posts Wider Y/Y Loss but Raises Kalydeco Outlook - An...
7/30/2015Large-Cap Healthcare Stocks Outperform Small Caps
7/30/2015Edited Transcript of VRTX earnings conference call or presen...
7/29/2015Vertex Reports Second Quarter 2015 Financial Results
7/29/2015Vertex reports 2Q loss
7/28/2015Will Vertex (VRTX) Surprise with a Lower Loss in Q2? - Analy...
7/28/2015CRBP: Warrant Exercise To Provide Sufficient Cash Through 20...
7/24/2015What to Watch in the Week Ahead and on Monday, July 27
7/21/2015How High? The Backlash Over Rising Prescription Drug Prices ...
7/14/2015Vertex to Announce Second Quarter 2015 Financial Results on ...
7/6/2015Vertex Pharma Is 'Hyped,' H.C. Wainwright Sees 35% Downside
7/5/2015Evercore ISI Analyst Gives Highlights From Vertex's Orkambi ...
7/5/20151:46 pm Vertex Pharma confirms FDA approval of its ORKAMBI t...
7/2/2015Business Highlights
7/2/2015ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacafto...
7/2/2015ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacafto...
7/2/2015ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacafto...
7/2/2015ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacafto...
7/2/2015FDA clears drug for leading form of cystic fibrosis
7/2/2015ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacafto...
7/2/2015ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacafto...
7/2/2015Vertex Pharma's lung disorder therapy wins FDA nod
7/2/2015Vertex Shares Leap On FDA Approval For Cystic Fibrosis Combo...
7/2/2015FDA Approves ORKAMBI™ (lumacaftor/ivacaftor) - the First Med...
6/18/2015Sangeeta N. Bhatia, M.D., Ph.D., Joins Vertex Board of Direc...
6/12/2015Edited Transcript of VRTX presentation 11-Jun-15 4:20pm GMT
5/8/2015FDA questions benefit of cystic fibrosis drug from Vertex
4/23/2015Why Vertex Pharmaceuticals (VRTX) Stock Might be a Great Pic...
4/21/2015Gilead's Stock Spikes on Possibility of Vertex Deal
4/21/2015Gilead-Vertex Deal Has 'Low Probability' Of Happening, RBC C...
4/21/2015Bernstein: It's Time For Gilead To Pull The Trigger On This ...
4/17/2015Biotech Investors Shouldn't Miss These Stocks This Earnings ...
4/15/2015Will a New Vertex Drug for Cystic Fibrosis Become a Budget B...
4/9/2015Vertex to Announce First Quarter 2015 Financial Results on A...
4/8/2015Stock Market News for April 08, 2015 - Market News
3/26/2015The Zacks Analyst Blog Highlights: Biogen, Prothena, Vertex,...
3/26/2015One analyst is convinced the biotech stock plunge is 'misgui...
3/24/2015Vertex Falls on Disappointing Kalydeco+VX-661 Combo Data - A...
3/24/2015Vertex Treatment May Have High Risk of Failure, Analyst Sugg...
3/24/2015Stock Market News for March 24, 2015 - Market News
3/23/2015Deutsche Bank: Vertex Pharma's Disappointing VX-661 Trial Re...
3/23/2015Vertex Falls Below Buy Point On Cystic-Fibrosis Drug Data
3/23/2015Pfizer and ImmunoGen are big market movers
3/23/2015ICYMI: Pharmaceutical Stocks Are Moving Big On Monday
Comments closed
 
Latest comment posted for this article
Be the first to comment
Add your comment
NASDAQ (VRTX)
468.00-0.12%
US$ 468.00
09/06 17:00 -0.570
-0.12%
Prev close Open
468.57 467.92
Low High
463.04 471.89
Year l/h YTD var.
392.81 -  505.78 13.89%
52 week l/h 52 week var.
343.00 -  505.78 36.42%
Volume 1 month var.
1,033,377 -0.096%
Produces
Develops
Explores for
 
 
 
Analyse
Interactive chart Add to compare
Interactive
chart
Print Compare Export
You must be logged in to use the porfolio and watchlists (free)
Top Newsreleases
MOST READ
Annual variation
DateVariationHighLow
202415.02%510.64391.02
202340.90%413.00282.41
202230.17%324.75219.10
2021-6.14%238.26176.36
20206.96%306.08197.47
 
5 years chart
 
3 months chart
 
3 months volume chart
 
 
Mining Company News
Plymouth Minerals LTDPLH.AX
Plymouth Minerals Intersects Further High Grade Potash in Drilling at Banio Potash Project - Plannin
AU$ 0.12-8.00%Trend Power :
Santos(Ngas-Oil)STO.AX
announces expected non-cash impairment
AU$ 6.90-0.36%Trend Power :
OceanaGold(Au)OGC.AX
RELEASES NEW TECHNICAL REPORT FOR THE HAILE GOLD MINE
AU$ 2.20+0.00%Trend Power :
Western Areas NL(Au-Ni-Pl)WSA.AX
Advance Notice - Full Year Results Conference Call
AU$ 3.86+0.00%Trend Power :
Canadian Zinc(Ag-Au-Cu)CZN.TO
Reports Financial Results for Q2 and Provides Project Updates
CA$ 0.12+4.55%Trend Power :
Stornoway Diamond(Gems-Au-Ur)SWY.TO
Second Quarter Results
CA$ 0.02+100.00%Trend Power :
McEwen Mining(Cu-Le-Zn)MUX
TO ACQUIRE BLACK FOX FROM PRIMERO=C2=A0
US$ 8.41-3.67%Trend Power :
Rentech(Coal-Ngas)RTK
Rentech Announces Results for Second Quarter 2017
US$ 0.20-12.28%Trend Power :
KEFIKEFI.L
Reduced Funding Requirement
GBX 0.58-0.68%Trend Power :
Lupaka Gold Corp.LPK.V
Lupaka Gold Receives First Tranche Under Amended Invicta Financing Agreement
CA$ 0.05+0.00%Trend Power :
Imperial(Ag-Au-Cu)III.TO
Closes Bridge Loan Financing
CA$ 2.06-0.96%Trend Power :
Guyana Goldfields(Cu-Zn-Pa)GUY.TO
Reports Second Quarter 2017 Results and Maintains Production Guidance
CA$ 1.84+0.00%Trend Power :
Lundin Mining(Ag-Au-Cu)LUN.TO
d Share Capital and Voting Rights for Lundin Mining
CA$ 11.47-4.50%Trend Power :
Canarc Res.(Au)CCM.TO
Canarc Reports High Grade Gold in Surface Rock Samples at Fondaway Canyon, Nevada
CA$ 0.30-1.67%Trend Power :
Havilah(Cu-Le-Zn)HAV.AX
Q A April 2017 Quarterly Report
AU$ 0.18-5.26%Trend Power :
Uranium Res.(Ur)URRE
Commences Lithium Exploration Drilling at the Columbus Basin Project
US$ 6.80-2.86%Trend Power :
Platinum Group Metals(Au-Cu-Gems)PTM.TO
Platinum Group Metals Ltd. Operational and Strategic Process ...
CA$ 1.60-3.03%Trend Power :
Devon Energy(Ngas-Oil)DVN
Announces $340 Million of Non-Core Asset Sales
US$ 41.34-1.76%Trend Power :
Precision Drilling(Oil)PD-UN.TO
Announces 2017Second Quarter Financial Results
CA$ 8.66-0.35%Trend Power :
Terramin(Ag-Au-Cu)TZN.AX
2nd Quarter Report
AU$ 0.04+0.00%Trend Power :
Take advantage of rising gold stocks
  • Subscribe to our weekly mining market briefing.
  • Receive our research reports on junior mining companies
    with the strongest potential
  • Free service, your email is safe
  • Limited offer, register now !
Go to website.